GINA DUNCAN: Open Payments
NPI 1790279107 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 13 payments from 8 companies in 2025. Trend: 2023 $125 · 2024 $147 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| BridgeBio Pharma, Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $27 |
| Amgen Inc. | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| HEARTFLOW, INC. | 1 | $14 |
Products named: JARDIANCE, Attruby, Kerendia, LifeVest, REPATHA, OPSYNVI, FARXIGA, FFRct.
Industry payments across PA — which companies pay providers there.
